News: commercialisation
VivaZome licenses University of Adelaide stem cell technology
VivaZome Therapeutics and 91×ÔÅÄ have entered into a series of agreements encompassing licensing of technology, access to stem cells and conduct of research, all in support of VivaZome’s mission to develop and commercialise exosome-based therapeutics.
[Read more about VivaZome licenses University of Adelaide stem cell technology ]
New barley variety 'Laperouse' released
French barley breeding company SECOBRA is proud to release its first variety in Australia after many years of collaborative research and development with 91×ÔÅÄ.
Amaero launches Adelaide 3D printing facility
Amaero International Limited (ASX:3DA), a world leader in metal additive manufacturing, officially launched their Adelaide facility today in partnership with 91×ÔÅÄ. The facility was opened by the South Australian Minister for Innovation and Skills, the Hon. David Pisoni MP.
[Read more about Amaero launches Adelaide 3D printing facility]
Investors inject $45m into SA health and biotech industry
The Adelaide China Biotech Investment Fund has today been launched – a new $45 million investment fund that will accelerate the development and commercialisation of health and bio-technologies from South Australia for the global market.
[Read more about Investors inject $45m into SA health and biotech industry]
![RSS News Feed](/global/images/rss.gif" "RSS News Feed"){kind=small}